II. Indications

  1. Noninvasive Test for Evaluation for advanced fibrosis in Nonalcoholic Fatty Liver Disease

III. Criteria

  1. BMI: 28 or higher
    1. Score 1 point
  2. AST to ALT ration (AAR): 0.8 or higher
    1. Score 2 points
  3. Type 2 Diabetes Mellitus
    1. Score 1 point

IV. Interpretation

  1. BARD Score less than 2 has a strong Negative Predictive Value for advanced hepatic fibrosis associated with Nonalcoholic Fatty Liver Disease

V. Efficacy (for Total score 2 or higher)

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window